Dutch ingredients group DSM has posted a 50% jump full-year profits, which were boosted by a strong performance at the group’s nutrition business.
Net profit rose to EUR507m (US$698m) during 2010 as sales – excluding discontinued operations – rose 22% to EUR8.17bn.
Go deeper with GlobalData
Commenting on the result, CEO Feike Sijbesma said that the group had remained focused on cost and cash management in the year to the end of December.
During the year, the group completed the EUR829m acquisition of Martek Biosciences. Hinting at possible future acquisitions and emphasising the company’s “strong” operating cash flow of EUR1.1bn, DSM said that it is in an “excellent position” to “pursue its strategic growth ambitions”.
Click here for DSM’s full results release.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
